A new design of a lentiviral shRNA vector with inducible co-expression of ARGONAUTE 2 for enhancing gene silencing efficiency
- PMID: 26649169
- PMCID: PMC4672530
- DOI: 10.1186/s13578-015-0058-2
A new design of a lentiviral shRNA vector with inducible co-expression of ARGONAUTE 2 for enhancing gene silencing efficiency
Abstract
Background: RNA interference (RNAi) is a robust tool for inhibiting specific gene expression, but it is limited by the uncertain efficiency of siRNA or shRNA constructs. It has been shown that the overexpression of ARGONAUTE 2 (AGO2) protein increases silencing efficiency. However, the key elements required for AGO2-mediated enhancement of gene silencing in lentiviral vector has not been well studied.
Results: To explore the application of AGO2-based shRNA system in mammalian cells, we designed shRNA vectors targeting the EGFP reporter gene and evaluated the effects of various factors on silencing efficiency including stem length, loop sequence, antisense location as well as the ratio between AGO2 and shRNA. We found that 19 ~ 21-bp stem and 6- or 9-nt loop structure in the sense-loop-antisense (S-L-AS) orientation was an optimal design in the AGO2-shRNA system. Then, we constructed a single lentiviral vector co-expressing shRNA and AGO2 and demonstrated that the simultaneous expression of shRNA and AGO2 can achieve robust silencing of exogenous DsRed2 and endogenous ID1 and P65 genes. However, the titers of packaged lentivirus from constitutive expression of AGO2 vector were extremely low, severely limiting its broad application. For the first time, we demonstrated that the problem can be significantly improved by using the inducible expression of AGO2 lentiviral system.
Conclusions: We reported a novel lentiviral vector with an optimal design of shRNA and inducible AGO2 overexpression which provides a new tool for RNAi research.
Keywords: AGO2; Lentivirus; RNAi; shRNA.
Figures
![Fig. 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4672530/bin/13578_2015_58_Fig1_HTML.gif)
![Fig. 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4672530/bin/13578_2015_58_Fig2_HTML.gif)
![Fig. 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4672530/bin/13578_2015_58_Fig3_HTML.gif)
![Fig. 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4672530/bin/13578_2015_58_Fig4_HTML.gif)
![Fig. 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4672530/bin/13578_2015_58_Fig5_HTML.gif)
![Fig. 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4672530/bin/13578_2015_58_Fig6_HTML.gif)
Similar articles
-
[Investigation of Lentiviral Vectors Based Integrin β8 RNAi System in Neonatal Rats' Brain].Sichuan Da Xue Xue Bao Yi Xue Ban. 2018 May;49(3):325-330. Sichuan Da Xue Xue Bao Yi Xue Ban. 2018. PMID: 30014628 Chinese.
-
Robust RNAi enhancement via human Argonaute-2 overexpression from plasmids, viral vectors and cell lines.Nucleic Acids Res. 2013 Nov;41(21):e199. doi: 10.1093/nar/gkt836. Epub 2013 Sep 17. Nucleic Acids Res. 2013. PMID: 24049077 Free PMC article.
-
Post-transcriptional gene silencing by RNA interference in non-mammalian vertebrate systems: where do we stand?Mutat Res. 2011 Nov-Dec;728(3):158-71. doi: 10.1016/j.mrrev.2011.09.001. Epub 2011 Sep 13. Mutat Res. 2011. PMID: 21930237 Review.
-
Co-expression of Argonaute2 Enhances Short Hairpin RNA-induced RNA Interference in Xenopus CNS Neurons In Vivo.Front Neurosci. 2009 Jul 9;3:63. doi: 10.3389/neuro.17.001.2009. eCollection 2009. Front Neurosci. 2009. PMID: 20582287 Free PMC article.
-
Short-term cytotoxic effects and long-term instability of RNAi delivered using lentiviral vectors.BMC Mol Biol. 2004 Aug 3;5:9. doi: 10.1186/1471-2199-5-9. BMC Mol Biol. 2004. PMID: 15291968 Free PMC article.
Cited by
-
Toward Tightly Tuned Gene Expression Following Lentiviral Vector Transduction.Viruses. 2020 Dec 11;12(12):1427. doi: 10.3390/v12121427. Viruses. 2020. PMID: 33322556 Free PMC article. Review.
References
-
- Maczuga P, Lubelski J, van Logtenstein R, Borel F, Blits B, Fakkert E, Costessi A, Butler D, van Deventer S, Petry H, et al. Embedding siRNA sequences targeting apolipoprotein B100 in shRNA and miRNA scaffolds results in differential processing and in vivo efficacy. Mol Ther J Am Soc Gene Ther. 2013;21(1):217–227. doi: 10.1038/mt.2012.160. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials